<DOC>
	<DOCNO>NCT00289510</DOCNO>
	<brief_summary>The objective study assess safety immunogenicity inactivate influenza vaccine ( whole virion , Vero cell derive ) . Subjects randomly assign receive single injection whole virion , Vero cell derive egg derive influenza vaccine Day 0 . Subjects return study site safety evaluation predetermine interval 180 day vaccination . Subjects also blood drawn predetermine interval measure immunologic response vaccination .</brief_summary>
	<brief_title>Safety Immunogenicity Study Inactivated Influenza Vaccine ( Whole Virion , Vero Cell Derived )</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female subject 18 45 year age , inclusive , day screening ; understand study , agree provision , give write informed consent prior study entry ; clinically healthy ( physical condition physician would reservations vaccinate influenza vaccine outside scope clinical study ) ; agree keep daily record symptom ; female capable bearing child negative urine pregnancy test result study entry agree employ adequate birth control measure duration study . Subjects receive influenza vaccination 2005/2006 influenza season and/or 2004/2005 influenza season ; receive vaccination within 2 week prior vaccination study ; suffer kind immunodeficiency ; suffer disease ( e.g . autoimmune disease ) undergo form treatment ( e.g . systemic corticosteroid ) expect influence immune response ; history inflammatory degenerative neurological disease ( e.g . Guillain Barr√© , multiple sclerosis ) ; receive blood transfusion immunoglobulin within 30 day study entry ; donate blood plasma within 30 day study entry ; history vaccine relate contraindicate event ( e.g. , anaphylaxis , allergy egg , allergy component test comparator vaccine , know contraindication ) ; rash , dermatologic condition tattoo may interfere injection site reaction rating ; know suspect problem alcohol drug abuse ; unable lead independent life result either physical mental handicap ; administer investigational drug within six week prior study entry ; concurrently participate clinical study include administration investigational product ; female , pregnant lactating ; member team conduct study dependent relationship study investigator . Dependent relationship include close relative ( i.e. , child , partner/spouse , sibling , parent ) well employee investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>